(NYSEMKT: SCPX) Scorpius Holdings's forecast annual revenue growth rate of 136.49% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.96%.
Scorpius Holdings's revenue in 2024 is $6,994,838.On average, 1 Wall Street analysts forecast SCPX's revenue for 2024 to be $742,258,458, with the lowest SCPX revenue forecast at $742,258,458, and the highest SCPX revenue forecast at $742,258,458.
In 2025, SCPX is forecast to generate $1,264,721,936 in revenue, with the lowest revenue forecast at $1,264,721,936 and the highest revenue forecast at $1,264,721,936.